A
Aldeyra Therapeutics (ALDX)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Aldeyra Therapeutics (ALDX)
Aldeyra Therapeutics, Inc. is a biotechnology company, which is engaged in developing immune-modulating therapies to treat ocular and systemic diseases. The Company's lead product candidate, reproxalap, is a treatment in late-stage development for dr... Read more
- USD4.16
- USD4.25
- USD4.09
- USD11.97
- 0.20%
- --
- 736.29k
- 247M
- 1.42
- -59.10%
Stock News
3 hours ago
Disney quarterly results are on deck. Here's what to expect
CNBC
4 hours ago
Southern Company announces upsize and pricing of $1.3 billion in aggregate principal amount of Series 2024A 4.50% Convertible Senior Notes due June 15, 2027
Yahoo
4 hours ago
Elon Musk talks Mars, AI, and threats to civilization — but not a word of Tesla
Yahoo
5 hours ago
Dow Jones Futures Fall: AI Stock Palantir Plunges On Earnings; Apple 'Let Loose' Event Next
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
